stringtranslate.com

Sodium calcium edetate

Sodium calcium edetate (sodium calcium EDTA), also known as edetate calcium disodium among other names, is a medication primarily used to treat lead poisoning,[2] including both short-term and long-term lead poisoning.[3] Sodium calcium edetate came into medical use in the United States in 1953.[3]

Chelation agent

Sodium calcium edetate is in the chelating agent family of medication.[3] It is a salt of edetate with two sodium and one calcium atoms.[4]It works by binding to a number of heavy metals, which renders them almost inert and allows them to leave the body in the urine.[3]

Edetate disodium (Endrate) is a different formulation which does not have the same effects.[3]

Medical use

Sodium calcium edetate's primary use is to treat lead poisoning,[2]for which it is an alternative to succimer.[3]It is given by slow injection into a vein or into a muscle.[2]

For lead encephalopathy sodium calcium edetate is typically used together with dimercaprol.[3]It may also be used to treat plutonium poisoning.[5]It does not appear to be useful for poisoning by tetra-ethyl lead.[3]

Side effects

Common side effects include pain at the site of injection.[3] Other side effects may include kidney problems, diarrhea, fever, muscle pains, and low blood pressure.[2] Benefits when needed in pregnancy are likely greater than the risks.[3]

History

Sodium calcium edetate came into medical use in the United States in 1953.[3] It is on the World Health Organization's List of Essential Medicines.[6]

References

  1. ^ "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 October 2023.
  2. ^ a b c d Stuart MC, Kouimtzi M, Hill SR, eds. (2009). WHO Model Formulary 2008. World Health Organization. pp. 59, 62, 65. hdl:10665/44053. ISBN 9789241547659.
  3. ^ a b c d e f g h i j k "Edetate Calcium Disodium". The American Society of Health-System Pharmacists. Archived from the original on 16 January 2017. Retrieved 8 January 2017.
  4. ^ Kasture AV (2008). Pharmaceutical Chemistry. Vol. I. Pragati Books Pvt. Ltd. p. 16.11. ISBN 9788185790121. Archived from the original on 16 January 2017.
  5. ^ Flanagan R, Jones A, Maynard RL (2003). Antidotes: Principles and Clinical Applications. CRC Press. p. 47. ISBN 9780203485071. Archived from the original on 16 January 2017.
  6. ^ Organization WH (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva,CH: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.